About Stephen Mason

Stephen Mason founded AuRIC Strategies in 2024. He brings over 25 years of health care policy experience, having served within Congress and FDA, as well as working for the innovative drug and biologic, biosimilar, generic drug, medical device, and health insurance industries. 

Previously, Stephen was an Executive Vice President at the consulting firm Greenleaf Health for nine years, where he managed the firm’s regulatory policy function and guided a broad array of FDA-regulated clients and their trade associations through user fee negotiations and critical corporate milestones. He also led U.S. regulatory policy for Amgen, where he advanced key priorities related to innovative biopharmaceuticals, biosimilar development, and combination product regulations. 

During his tenure at FDA, Stephen served as the Assistant Commissioner for Legislation under both the George W. Bush and Obama Administrations, where he managed legislative policy for the Agency and was the primary liaison between the Administration and Congress on product regulations and initiatives impacting the innovative biopharmaceutical, biosimilar, generic drug, medical device, and food industries.  

Stephen is originally from Detroit, Michigan, and first came to Washington, D.C. after working across the country on political campaigns.  He holds a Bachelor of Science in Business Administration & Finance from Oakland University in Rochester, MI.  He currently lives in Arlington, VA, with his wife and three sons.